MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$31,869K
Free Cash flow
$28,011K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from revolving line of ...
Net income
Share-based compensation
Others
Negative Cash Flow Breakdown
Payments of revolving line of cr...
Acquisition, net of cash acquire...
Payments for employee share-base...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-04-26
2026-01-25
2025-10-26
2025-07-27
Net income
26,563
-29,795
-2,862
-27,064
Depreciation and amortization
9,161
10,174
10,129
10,314
Amortization of right-of-use assets
1,574
1,428
1,392
1,356
Right-of-use asset impairment
-
0
-
-
Investment impairments and credit loss reserves, net
-
10,387
0
0
Impairment of goodwill
-
42,794
0
41,991
Intangible impairment
-
1,777
-
-
Accretion of deferred financing costs
1,090
1,091
1,172
1,271
Write-off of deferred financing costs
-2,388
-
1,872
364
Write-off of deferred financing cost and debt discount
-
2,388
-
-
Loss on extinguishment of debt
-
0
0
0
Induced conversion expense
-
0
21,188
-
Interest rate swap termination
0
0
416
743
Deferred income taxes
-1,844
-91
-2,935
-2,437
Share-based compensation
26,446
16,453
17,138
17,297
Loss on disposition of business operations and assets
-8
-34
1
-16
Equity method income
1,621
-364
16
-62
Gain from sale of investments
100
0
0
0
Corporate-owned life insurance, net
-2,393
-708
-820
-734
Amortization of inventory step-up
-
0
-
-
Accounts receivable, net
14,055
-5,442
11,317
-12,325
Inventories
7,180
8,575
2,449
13,001
Other assets
3,155
6,485
2,778
5,051
Accounts payable
8,044
6,889
4,416
1,420
Accrued liabilities
-13,681
10,411
6,040
4,004
Other liabilities
-1,148
-1,701
199
-3,337
Net cash provided by operating activities
36,183
61,487
47,462
44,395
Proceeds from sales of property, plant and equipment
42
5
0
3
Purchase of property, plant and equipment
8,172
2,430
2,819
2,884
Proceeds from sale of investments
100
0
1,400
0
Purchase of investments
-
0
0
0
Purchase of intangibles
5,274
608
2,635
2,250
Acquisition, net of cash acquired
29,188
21,472
-
-
Proceeds from corporate-owned life insurance
-
0
0
0
Premiums paid for corporate-owned life insurance
0
0
0
0
Net cash used in investing activities
-42,492
-24,505
-4,054
-5,131
Proceeds from revolving line of credit
50,000
0
-
-
Payments of revolving line of credit
50,000
0
0
-
Payments of term loans
0
0
171,212
-
Proceeds from convertible senior notes
-
0
402,500
-
Payments of convertible senior notes
-
0
280,950
-
Repurchase of warrants
-
0
217,761
-
Proceeds from unwind of convertible note hedge
-
0
242,251
-
Purchase of capped calls
-
0
31,395
-
Payments of term loans
-
-
-
35,000
Proceeds from issuance of common stock, net of issuance costs
-
0
-
-
Proceeds from interest rate swap termination
-
0
58
237
Deferred financing costs
0
1,027
10,062
72
Payments for employee share-based compensation payroll taxes
26,585
8,549
6,553
3,290
Proceeds from exercise of stock options
787
2,612
1,038
468
Distributions to noncontrolling interest
-
0
0
0
Net cash used in financing activities
-25,798
-6,964
-47,086
-27,657
Effect of foreign exchange rate changes on cash and cash equivalents
238
491
-212
479
Net (decrease) increase in cash and cash equivalents
-31,869
30,509
-3,890
12,086
Cash and cash equivalents at beginning of period
195,179
156,474
156,474
156,474
Cash and cash equivalents at end of period
163,310
195,179
164,670
168,560
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$26,563K
(37.31%↑ Y/Y)
Share-based compensation
$26,446K
(286.92%↑ Y/Y)
Depreciation and
amortization
$9,161K
(-10.10%↓ Y/Y)
Accounts payable
$8,044K
(-17.96%↓ Y/Y)
Corporate-owned life insurance,
net
-$2,393K
(-265.34%↓ Y/Y)
something is missing
$2,388K
Deferred income taxes
-$1,844K
(23.52%↑ Y/Y)
Amortization of right-of-use
assets
$1,574K
(16.94%↑ Y/Y)
Accretion of deferred
financing costs
$1,090K
(-13.08%↓ Y/Y)
Loss on disposition
of business...
-$8K
(69.23%↑ Y/Y)
Net cash provided by
operating activities
$36,183K
(30.04%↑ Y/Y)
Effect of foreign
exchange rate changes on...
$238K
(-82.23%↓ Y/Y)
Canceled cashflow
$43,328K
Net (decrease)
increase in cash and cash...
-$31,869K
(-773.62%↓ Y/Y)
Canceled cashflow
$36,421K
Proceeds from sale of
investments
$100K
(-81.34%↓ Y/Y)
Proceeds from sales of
property, plant and...
$42K
Proceeds from revolving
line of credit
$50,000K
Proceeds from exercise of
stock options
$787K
(2359.38%↑ Y/Y)
Accounts receivable, net
$14,055K
(352.37%↑ Y/Y)
Accrued liabilities
-$13,681K
(11.42%↑ Y/Y)
Inventories
$7,180K
(8.34%↑ Y/Y)
Other assets
$3,155K
(238.32%↑ Y/Y)
Write-off of deferred
financing costs
-$2,388K
(55.32%↑ Y/Y)
Equity method income
$1,621K
(54.97%↑ Y/Y)
Other liabilities
-$1,148K
(-331.58%↓ Y/Y)
Gain from sale of
investments
$100K
Net cash used in
investing activities
-$42,492K
(-737.94%↓ Y/Y)
Canceled cashflow
$142K
Net cash used in
financing activities
-$25,798K
(-33.25%↓ Y/Y)
Canceled cashflow
$50,787K
Acquisition, net of cash
acquired
$29,188K
Purchase of property,
plant and equipment
$8,172K
(395.27%↑ Y/Y)
Purchase of intangibles
$5,274K
(896.98%↑ Y/Y)
Payments of revolving
line of credit
$50,000K
Payments for employee
share-based compensation...
$26,585K
(198.67%↑ Y/Y)
Buy us a coffee
semtech-logo-svg
SEMTECH CORP (SMTC)
semtech-logo-svg
SEMTECH CORP (SMTC)